As of 2024-12-15, the EV/EBITDA ratio of Oasmia Pharmaceutical AB (OASM.ST) is -10.15. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OASM.ST's latest enterprise value is 1,383.31 mil Oasmia Pharmaceutical. OASM.ST's TTM EBITDA according to its financial statements is -136.30 mil Oasmia Pharmaceutical. Dividing these 2 quantities gives us the above OASM.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 21.9x | 18.2x |
| Forward P/E multiples | 9.0x - 27.7x | 18.4x |
| Fair Price | (4.48) - (6.81) | (5.72) |
| Upside | -253.5% - -333.2% | -295.9% |
| Date | EV/EBITDA |